Content on this page requires a newer version of Adobe Flash Player.
English
|
Indonesia
Site
Web
Home
About Kalbe
Kalbe in Brief
CEO Message
Board of Commissioners
Board of Directors
Kalbe Group Structure
Awards
Corporate Governance
Structure of Corporate Governance
General Meeting of Shareholders (GMS)
Board of Commissioners
Board of Directors
Audit Committee
Nomination Committee
Remuneration Committee
Business Risk Committee
GCG Committee
Internal Audit and Internal Control
External Audit
Risk Management
Corporate Secretary and Investor Relations
Commitment to Consumers
Ethics
Whistleblowing System
Corporate Values
Vision and Mission
Panca Sradha
Human Resources
Offices and Representatives
Products and Services
Prescription
Product A-Z
Consumer Health
Product A-Z
Nutritionals
Product A-Z
Healthcare Services
Mitrasana
Pharma Metric Labs
Animal Health
Product A-Z
Distribution & Logistics
Medical Devices
Research and Development
Stem Cell and Cancer Institute
Innogene Kalbiotech
CSR
Education
Health
Facilites and Infrastructures
Environment
Business Opportunity
Partners
Joint Venture
Supplier
Integrity
Innovation
Comprehensive
Investor
News
Careers
KLBF
20/06/2013
11:06 AM
Last (IDR):
1270
Kalbe’s First Quarter 2013 Sales Increased by 16.2%
Innogene Kalbiotech received an award from Frost & Sullivan Asia Pacific 2012
Announcement of Medical Representative Candidates Passed Medical Test